Tower Research Capital (TRC)’s BioStem Technologies BSEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35K Buy
+760
New +$2.89K ﹤0.01% 5093

Other funds holding BSEM

Tower Research Capital (TRC)'s BSEM Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in BioStem Technologies (BSEM) in Q3 2026: 760 shares worth $2.35K. The stake represents ﹤0.01% of the portfolio and ranks #5093 among its holdings.

26 funds tracked by Wall St. Rank hold BSEM as of Q3 2026.

  • Tower Research Capital (TRC) held 760 shares of BioStem Technologies worth $2.35K as of Q3 2026.
  • BioStem Technologies was a new Tower Research Capital (TRC) position in Q3 2026.
  • BioStem Technologies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5093 holding.
  • 26 funds tracked by Wall St. Rank held BioStem Technologies as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.